Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
{{output}}
Background: Crohn's disease is a chronic, relapsing inflammatory disease of the gastrointestinal tract. We aimed to assess the efficacy and safety of duvakitug, an anti-TNF-like cytokine 1A monoclonal antibody, in adults with mo... ...
